Low Dose Rivaroxaban for Atherosclerotic Cardiovascular Diseases: A Systematic Review and Meta-analysis

• Egile Nagusiak: Can Chen (Egilea), Yuanqing Kan (Egilea), Zhenyu Shi (Egilea), Daqiao Guo (Egilea), Weiguo Fu (Egilea), Yanli Li (Egilea), Qianzhou Lv (Egilea), Xiaoyu Li (Egilea), Yi Si (Egilea)
• Formatua: Liburua
• Argitaratua: Frontiers Media S.A., 2021-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Background: This study aims to explore the role of low-dose rivaroxaban (≤10 mg daily) for the treatment of atherosclerotic cardiovascular disease (ASCVD).Methods: PubMed, Embase and the Cochrane Library were searched for randomized controlled trials (RCTs) of low-dose rivaroxaban in patients with A...